RecruitingNCT07020364

Feasibility and Safety of a Single Working Element for Bipolar and Laser Enucleation in Prostate Surgery: A Prospective Study

Sponsor

Menoufia University

Enrollment

60 participants

Start Date

Oct 1, 2024

Study Type

OBSERVATIONAL

Conditions

Prostate BPH (Benign Prostatic Hyperplasia)

Summary

A prospective feasibility study would be a practical first step, focusing on real-time assessment and ensuring the new working element's integration is safe and effective before broader clinical trials.

Eligibility

Sex: MALEMin Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called A single working element for bipolar enucleation and a medical device called A single working element for laser enucleation for people with bph (benign prostatic hyperplasia) and prostate. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEA single working element for bipolar enucleation

Device: A single working element compatible with both bipolar and laser modalities. The bipolar energy will be used for cutting and coagulation during enucleation.

DEVICEA single working element for laser enucleation

Device: A single working element compatible with both bipolar and laser modalities. Thulium or Holmium laser will be employed for tissue dissection and hemostasis.

Locations(1)

Menoufia Faculty of Medicine

Shibīn al Kawm, Menoufia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07020364

Related Trials

Collection of Blood From Patients With Prostate Cancer

NCT009232211 location

A Single-center, Single-arm Study to Evaluate the Safety and Efficacy of Ultra-minimally Invasive Prostate Dilation in Treating Patients With Significant Obstructive Symptoms Caused by Benign Prostatic Hyperplasia

NCT075837061 location